{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:34:24Z","timestamp":1792679664026,"version":"4.5.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T00:00:00Z","timestamp":1383523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079188","type":"journal-article","created":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T22:03:59Z","timestamp":1383602639000},"page":"e79188","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neuroprotection in a Novel Mouse Model of Multiple Sclerosis"],"prefix":"10.1371","volume":"8","author":[{"given":"Katie","family":"Lidster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"A Compston","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","article-title":"Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease","volume":"206","author":"C Bjartmar","year":"2003","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.04.009","article-title":"Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis","volume":"165","author":"G Pryce","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1474-4422(12)70059-5","article-title":"Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects","volume":"11","author":"JA Cohen","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"LS Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/1352458511398885","article-title":"Critical appraisal of animal models of multiple sclerosis","volume":"17","author":"D Baker","year":"2011","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"L Steinman","year":"2006","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.msard.2011.09.001","article-title":"Practical guide to the induction of relapsing progressive experimental autoimmune encephaolomyelitis in the Biozzi ABH mouse","volume":"1","author":"S Al-Izki","year":"2012","journal-title":"Multiple Sclerosis Relat Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneuroim.2008.05.034","article-title":"An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss","volume":"201-202","author":"DW Hampton","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0165-5728(97)00203-8","article-title":"Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease","volume":"82","author":"JK O\u2019Neill","year":"1998","journal-title":"J Neuroimmunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2006.05.019","article-title":"Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice","volume":"178","author":"Y Guan","year":"2006","journal-title":"J Neuroimmunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","article-title":"Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice","volume":"116","author":"E Bettelli","year":"2006","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","article-title":"Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP","volume":"28","author":"G Feng","year":"2000","journal-title":"Neuron"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(93)90074-Z","article-title":"Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity","volume":"72","author":"J Goverman","year":"1993","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000228720","article-title":"Identification of Suitable Normalizing Genes for Quantitative Real-Time RT-PCR Analysis of Gene Expression in Fetal Mouse Gonads","volume":"3","author":"T Svingen","year":"2009","journal-title":"Sexual Dev"},{"key":"ref16","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"143","author":"SJ Piddlesden","year":"1993","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"E Bettelli","year":"2003","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneumeth.2004.03.007","article-title":"Optokinetic test to evaluate visual acuity of each eye independently","volume":"138","author":"BB Thomas","year":"2004","journal-title":"J Neurosci Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bjo.2008.150482","article-title":"Longitudinal profile of retinal ganglion cell damage assessed with blue-light confocal scanning laser ophthalmoscopy after ischaemic reperfusion injury","volume":"93","author":"CKS Leung","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2009.10.077","article-title":"Cyan fluorescent protein (CFP) expressing cells in the retina of Thy1-CFP transgenic mice before and after optic nerve injury","volume":"468","author":"X Wang","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0002-9440(10)64436-7","article-title":"A Role for Caspase-1 and -3 in the Pathology of Experimental Allergic Encephalomyelitis : Inflammation Versus Degeneration","volume":"161","author":"Z Ahmed","year":"2002","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(02)00040-1","article-title":"Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice","volume":"125","author":"MM Morris-Downes","year":"2002","journal-title":"J Neuroimmunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"LS Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-010-0005-1","article-title":"Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration","volume":"8","author":"KM Galetta","year":"2011","journal-title":"Neurother J American Society For Experimental NeuroTherapeutics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#","article-title":"Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis","volume":"46","author":"AJ Coles","year":"1999","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0735","article-title":"Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis[mdash]current status","volume":"4","author":"SG Waxman","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10443","article-title":"Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration","volume":"53","author":"K Raju","year":"2003","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"M Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.immuni.2012.09.009","article-title":"The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity","volume":"38","author":"JM Coquet","year":"2013","journal-title":"Immunity"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.expneurol.2011.09.030","article-title":"Sodium channels and microglial function","volume":"234","author":"JA Black","year":"2012","journal-title":"Exp Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bjo.84.8.922","article-title":"Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies","volume":"84","author":"F Hafezi","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of Neuronal Dysfunction and Degeneration in Multiple Sclerosis","volume":"93","author":"R Dutta","year":"2011","journal-title":"Prog Neurobiol"},{"key":"ref33","first-page":"S209","article-title":"Selective targeting of neuroprotection to MS lesions: sodium channel blockers in experimental autoimmune encephalomyelitis","volume":"17","author":"S Al-Izki","year":"2011","journal-title":"Mult Scler"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00415-006-0204-1","article-title":"Axonal protection achieved in a model of multiple sclerosis using lamotrigine","volume":"253","author":"DA Bechtold","year":"2006","journal-title":"J Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e70019","DOI":"10.1371\/journal.pone.0070019","article-title":"Biomarker report from the phase II lamotrigine trial in secondary progressive MS-neurofilament as a surrogate of disease progression","volume":"8","author":"S Gnanapavan","year":"2013","journal-title":"PLOS ONE"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(10)70131-9","article-title":"Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"9","author":"R Kapoor","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref37","first-page":"1","article-title":"Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine","volume":"258","author":"T Hayton","year":"2011","journal-title":"J Neurol"},{"key":"ref38","article-title":"Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis. Multiple sclerosis (Houndmills, Basingstoke, England) 17: 939\u2013948","author":"S Al-Izki","year":"2011"},{"key":"ref39","article-title":"Neuromyelitis optica: an antibody-mediated disorder of the central nervous system","volume":"2012","author":"J Oh","year":"2012","journal-title":"Neurology Res International"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"S Mader","year":"2011","journal-title":"J Neuroinflammation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/WNO.0b013e31823a9ebc","article-title":"Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis","volume":"32","author":"DB Fernandes","year":"2012","journal-title":"J Neuro Ophthalmol Off J North American Neuro Ophthalmology Society"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T06:28:22Z","timestamp":1716100102000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079188"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Villoslada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,4]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079188","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,4]]}}}